Amneal Pharmaceuticals
Generic Drug Manufacturer
Based in NJ
AI Overview
With $450K in lobbying spend across 9 quarterly filings, Amneal Pharmaceuticals is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2020 to 2022.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $170K |
| 2021 | $240K |
| 2022 | $40K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Amneal Pharmaceuticals disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Pharmacy
Issues related to the generic drug industry
Biomedical Advanced Research and Development Authority, Pharmaceutical Manufacturing, Supply Chain
Pharmaceutical Manufacturing, Supply Chain, House GOP China Task Force
H.R. 938- BLOCKING Act of 2019
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.